How does sharewise work?
Discuss
Discuss and share predictions for your favorite stocks in the forum. Let your opinion be heard
Show moreTop Buy/Sell (This Month)
| Security | Price | Target price |
|---|---|---|
| Rheinmetall AG | €1,875.5 | €2,050.0 |
| Micron Technology Inc. | €285.45 | €298.17 |
| NVIDIA Corp. | €156.70 | €192.38 |
| Security | Price | Target price |
|---|---|---|
| Arbor Realty Trust Inc. | €6.61 | €6.83 |
| Carmax Inc. | ? | €69.19 |
| Fortinet Inc. | €65.89 | €97.11 |
New Top predictions since last week
| Prediction | User | Perf. (%) |
|---|---|---|
| B ImmunityBio Inc. | MarketIPO81 | 34.08% |
| B Reconnaissance Energy Afri.ltd | TurnoverIndustry36 | 32.26% |
| B Apex Critical Metals Corp. | RudolfL | 23.88% |
| Prediction | User | Perf. (%) |
|---|---|---|
| S 11880 Solutions AG | thomasw | -57.65% |
| S 11880 Solutions AG | Vassago1 | -50.00% |
| S Rubean AG | thomasw | -20.73% |
Many tell you which stocks to buy.
We measure how often they are right!
Portfolios of our members
Exploits Discovery
When it comes to stocks, what is important for you?
Find stocks based on your criteria with our sharewise stock finder. All results are based on thousands of votes by our community
Pros and Cons of these stocks (New Predictions)
Rheinmetall AG
WKN: 703000 / Name: Rheinmetall / Stock / Automobiles & Auto Parts / Mid Cap /
Pros
Cons
_0.png?locale=us){kind=logo}
BioNTech SE ADR
WKN: A2PSR2 / Name: BioNTech / Stock / Mid Cap /
Pros
Cons
Try sharewise+ and get hundreds more matching stocks
Sign up for free!Tops & Flops S&P 500
| Security | Price | Change(%) (%) |
|---|---|---|
| PerkinElmer Inc. | €94.60 | 5.900% |
| Discovery Communications C | €22.42 | 5.110% |
| NVR Inc. | €6,350.0 | 4.100% |
| Lam Research Corp. | €7,371.0 | 3.990% |
| Westrock Co | €47.53 | 3.930% |
| Security | Price | Change(%) (%) |
|---|---|---|
| Wells Fargo & Co. | €76.11 | -5.220% |
| Robert Half International | €24.00 | -4.800% |
| Intuit Inc. | €499.00 | -3.980% |
| Royal Caribbean Cruises | €240.90 | -3.810% |
| Intuitive Surgical Inc | €465.60 | -3.490% |
Courses
sharewise advanced features
Also you get more information about our Pro and Cons feature, where we bring the wisdom of crowds to a new level.
For discussing with your friends and managing your investment clubs we will show you how to create your own stock debates.#
sharewise Introduction
Predictions
Top News
Power Struggle: Why Big Tech Is Buying Nuclear Stocks
Artificial Intelligence (AI) has hit a physical wall. For the last decade, the primary constraint on technology growth was computing power, or how many chips a company could buy. In 2026, the
3 Underfollowed Stocks Wall Street Still Likes—And for Good Reason
Despite major gains by a small number of mega-cap tech firms last year, the market rewarded investors willing to take a chance on some slightly less well-known stocks in 2025. Among the best
Tech Wreck or Valuation Reset? Rotating to Value in 2026
Volatility is returning to Wall Street, signaling a potential fracture in the bull market sentiment that defined the previous year. Recent trading sessions have seen Nasdaq futures face noticeable
Eli Lilly Stock Rallies as Ventyx Deal Calms Wegovy Concerns
In the last few months of 2025, shares of pharmaceutical giant Eli Lilly and Company (NYSE: LLY) went on an undeniable hot streak. From the beginning of August 2025 to the end of the year, the
JPMorgan Signals a Strong Year Ahead: Is JPM Headed for $400?
A convergence of factors has JPMorgan Chase & Company (NYSE: JPM) stock poised to rally in 2026. The stock surged in 2025 and could advance as much as 20% by year’s end. Below, we'll examine
BRK.B vs. CB: Which Insurer is a Safer Option for a Solid Portfolio?
The insurance industry is witnessing soft pricing. Per Global Insurance Market Index by Marsh, global commercial insurance rates fell 4% in the third quarter, following seven years of rising rates
Is it Apt to Hold Edwards Lifesciences Stock in Your Portfolio Now?
Edwards Lifesciences EW is well-poised to grow in the coming quarters owing to the strong adoption of its premium surgical technologies worldwide. The Transcatheter Mitral and Tricuspid Therapies
What's Next for Tilray Brands After Posting Record Q2 Revenues?
Tilray Brands TLRY delivered net revenues of $217.5 million in the second quarter of fiscal 2026, a quarterly record driven by strong results in the company’s international operations. On a
3 Sales Growth Picks to Bet on for Steady Returns in 2026
As 2026 begins, now is an ideal time to review your portfolio and fine-tune it for stronger returns. Several key themes from 2025 are still shaping markets — optimism around AI, the Federal
PFE Market Cap Falls More Than $7B in a Month: How to Play the Stock
Pfizer PFE stock has declined almost 5% in a month, losing $7.3 billion in market capitalization. Shares dipped recently after the company announced its financial guidance for 2026, which fell short
Ford Stock Up 40% in a Year & Still Looks Cheap: Should You Buy?
Shares of U.S. legacy automaker Ford F have surged more than 40% over the past year, handily outperforming the industry. Despite that, the company still appears undervalued. Ford trades at a forward
News
Walmart Stock Hits 52-Week High: Should You Stay Invested?
Walmart Inc. WMT touched a new 52-week high of $120.51 on Jan. 13 before closing modestly lower at $120.36, reflecting continued investor interest in the stock. The move highlights confidence in
IVZ's December AUM Rises on Inflows Despite Weak Markets, Stock Down
Invesco IVZ announced its preliminary assets under management (AUM) of $2.17 trillion for December 2025, representing a 0.7% increase from the previous month.Despite the increase in AUM, IVZ’s
GFI Soars 224% in a Year: How Should Investors Play the Stock?
Gold Fields Limited GFI has gained 224.2% over the past year compared with the Zacks Mining-Gold industry’s 151.6% increase and the S&P 500’s 19.8% rise.
Among its peers, Agnico Eagle Mines Limited
Will the Refining Business Continue to be Favorable for Phillips 66?
With West Texas Intermediate (WTI) oil prices currently hovering around $60 per barrel, according to data from Oilprice.com, which is significantly lower than a year ago, the overall energy business
da Vinci 5 Expands Globally: Can ISRG Beat Overseas Cost Hurdles?
Intuitive Surgical’s ISRG da Vinci 5 is in early stages of international rollout, which represents long-term opportunity for the company. However, the rollout may face potential hurdles in the near
Will a Surge in US Defense Spending Boost LMT's Prospects?
Lockheed Martin LMT could benefit from the proposed increase in U.S. defense spending under President Trump’s plan, which targets annual military expenditures of around $1.5 trillion by 2027. This
D-Wave Quantum's Expanded Global Customer Base Is Gaining Attention
During the third quarter of 2025, D-Wave Quantum QBTS signed several new and renewed customer agreements across both commercial and research applications, reflecting growing adoption of its quantum
Should You Continue to Hold Thermo Fisher Stock in Your Portfolio Now?
Thermo Fisher Scientific Inc.’s TMO recent slew of strategic collaborations reflects its ongoing commitment to sustainable long-term growth. Additionally, the slew of product launches is expected to
Is FFHCX a Strong Bond Fund Right Now?
If you have been looking for High Yield - Bonds funds, a place to start could be Fidelity Series Floating Rate Hgh Income (FFHCX). FFHCX has a Zacks Mutual Fund Rank of 1 (Strong Buy), which is
Contest
Still running
sharewise
Du findest das sharewise Projekt spannend und möchtest es unterstützen?
Mit einer
sharewise+-Mitgliedschaft
unterstützt du uns finanziell und bekommst zusätzliche Funktionalitäten freigeschalten.
Leeway
Die Analyse-Plattform Leeway untersucht mit KI-unterstützten Algorithmen aussagekräftige Zusammenhänge am Aktienmarkt. Anhand von vielen Millionen Datenpunkten finden die Algorithmen die Kennzahlen und Bewegungen, die nachweisbare Auswirkungen haben und Vorteile schaffen.
Kostenlos ausprobieren
Heibel Ticker
sharewise sagt: Stephan Heibel ist ein langähriger Unterstützer und Autor der Wunschanalyse. Er betreibt meiner Meinung nach einen der besten Börsenbriefe. Es gibt eine kostenlose und eine Premium Variante.
Kostenlos ausprobierensharewise
Du findest das sharewise Projekt spannend und möchtest es unterstützen?
Mit einer
sharewise+-Mitgliedschaft
unterstützt du uns finanziell und bekommst zusätzliche Funktionalitäten freigeschalten.